Question follow-through · 30221
Terminally Ill Adults (End of Life) Bill
To ask the Leader of the House, what steps she is taking to provide parliamentary scrutiny of Government involvement in amendments to the Terminally Ill Adults (End of Life) Bill by hon. Members not on the bill committee.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Leader of the House
- Tabled
- 10 Feb 2025
- Target answer date
- 13 Feb 2025
- Answer
- 13 Feb 2025 · 3 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Feb 2025
Question tabled
To ask the Leader of the House, what steps she is taking to provide parliamentary scrutiny of Government involvement in amendments to the Terminally Ill Adults (End of Life) Bill by hon. Members not on the bill committee.
13 Feb 2025
Target answer date
Date supplied by the official written-questions record.
13 Feb 2025
Answer published
While the Government have a neutral position on the principles of the Bill, we have a responsibility to ensure that any Bill passed by the House is workable and operable. The Terminally Ill Adults (End of Life) Bill was passed by the House at Second Readi...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.